| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Shields Matthew | EVP, Global Operations | C/O TEVA PHARMACEUTICAL INDUSTRIES LTD., 124 DVORA HANEVI'A ST.,, TEL AVIV, ISRAEL | /s/ Dov Bergwerk as attorney-in-fact for Matthew Shields | 05 Jun 2025 | 0002025621 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TEVA | Ordinary Shares | Options Exercise | +16,195 | 16,195 | 03 Jun 2025 | Direct | F1, F2 | |||
| transaction | TEVA | Ordinary Shares | Sale | $105,628 | -6,206 | -38% | $17.02 | 9,989 | 03 Jun 2025 | Direct | F1, F3 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TEVA | Restricted Share Units | Options Exercise | $0 | -16,195 | -25% | $0.000000 | 48,587 | 03 Jun 2025 | Ordinary Shares | 16,195 | Direct | F1, F2, F4 |
| Id | Content |
|---|---|
| F1 | The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. |
| F2 | Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. |
| F3 | Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II. |
| F4 | Restricted share units were granted on June 3, 2024 with 16,195 vested on June 3, 2025, 16,195 vesting on each of June 3, 2026 and June 3, 2027, and 16,197 vesting on June 3, 2028. |